PRESS RELEASE published on 03/31/2025 at 17:40, 1 year 6 months ago VALBIOTIS SA: Valbiotis® strengthens its foothold in pharmacies with two strategic partnerships Valbiotis strengthens its foothold in pharmacies through strategic partnerships with Apothical and Solution Réseau d'Achat, optimizing distribution and reinforcing its position in the pharmacy market Strategic Partnerships Valbiotis Distribution Pharmacies Pharmacy Market
BRIEF published on 03/18/2025 at 09:56, 1 year 7 months ago Valbiotis: Monthly update on capital and voting rights Share Capital Voting Rights Euronext Growth Valbiotis Threshold Crossing
BRIEF published on 03/18/2025 at 09:55, 1 year 7 months ago Total Number of Voting Rights and Shares of Valbiotis SA Share Capital Voting Rights Actions Transparency Euronext Growth
BRIEF published on 03/17/2025 at 17:45, 1 year 7 months ago Valbiotis Introduces Cholesterol Management Alternative Amid Regulatory Changes Regulation Valbiotis Lipidrive Cholesterol Management Red Yeast Rice
PRESS RELEASE published on 03/17/2025 at 17:40, 1 year 7 months ago VALBIOTIS SA: In anticipation of a change in regulations, Valbiotis® offers a scientifically proven alternative to red yeast rice for cholesterol management Valbiotis® offers a scientifically proven alternative to red yeast rice for cholesterol management in response to changing regulations. Learn about Valbiotis®PRO Cholesterol Valbiotis Lipidrive Health Supplements Cholesterol Management Red Yeast Rice
BRIEF published on 03/03/2025 at 17:45, 1 year 7 months ago Valbiotis 2024 financial results and future ambitions Valbiotis International Expansion Financial Strategy Food Supplements Results 2024
PRESS RELEASE published on 03/03/2025 at 17:40, 1 year 7 months ago VALBIOTIS SA: Valbiotis unveils its annual financial statements and confirms its strategic and financial goals Valbiotis unveils its annual financial statements & confirms strategic and financial goals for 2027 & 2030. Company reports fiscal year 2024 results indicating progress and transformation Financial Statements Valbiotis Annual Results Strategic Goals Commercialization Phase
BRIEF published on 02/24/2025 at 10:18, 1 year 7 months ago VALBIOTIS: Monthly Report of Voting Rights and Shares Share Capital Voting Rights Actions Euronext Growth Valbiotis
BRIEF published on 02/24/2025 at 10:17, 1 year 7 months ago VALBIOTIS SA: Monthly update on voting rights and shares Voting Rights Euronext Actions Valbiotis Financial Regulation
BRIEF published on 02/17/2025 at 12:05, 1 year 8 months ago VALBIOTIS: Information on Shares and Voting Rights Share Capital Voting Rights Euronext Growth Valbiotis Threshold Crossing
Published on 10/23/2026 at 16:00, 59 minutes ago Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award
Published on 10/23/2026 at 13:23, 3 hours 36 minutes ago Slam Mobilizes Drill Team to Moose Lake, Intersecting Broad Zones of Brecciated and Altered Rock With Visible Stibnite Along the Moose Lake Fault Zone
Published on 10/23/2026 at 13:00, 3 hours 59 minutes ago First Canadian Graphite Inc. Announces Flow-Through Financing
Published on 10/23/2026 at 02:20, 14 hours 39 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 17 hours 29 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/23/2026 at 16:40, 19 minutes ago THE POWER OF WILL: A SERIES OF CONVERSATIONS ABOUT DETERMINATION AND INDIVIDUALITY
Published on 10/23/2026 at 16:25, 34 minutes ago Lassa introduces new winter tyre Wintus 3 for light commercial vehicles
Published on 10/23/2026 at 16:10, 49 minutes ago EQS-Adhoc: SGL Carbon sells its former Carbon Fiber facility in Moses Lake (USA)
Published on 10/23/2026 at 15:48, 1 hour 10 minutes ago EU RIS CSDS Individual - Appointment of Custodian
Published on 10/22/2026 at 18:00, 22 hours 59 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 22 hours 59 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 22 hours 59 minutes ago H1 2026: marked improvement in operating results
Published on 10/22/2026 at 17:47, 23 hours 12 minutes ago Aéroports de Paris SA - 2026 9-month revenue